KROS — KEROS THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in KEROS THERAPEUTICS INC (KROS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 100,141 +56,157 +127.7% 0.00% $1.6M $15.82
2025 Q1 ADDED 43,984 +39,459 +872.0% 0.00% $448K $10.19
2024 Q3 REDUCED 4,525 -15,307 -77.2% 0.00% $263K $58.07
2024 Q2 REDUCED 19,832 -87 -0.4% 0.00% $906K $45.70
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KROS price (monthly, adj. close)

Other funds also holding KROS

As of 2025 Q4 — sorted by position size

Rangeley Capital, LLC 1.64% Madison Avenue Partners, LP 3Y 0.72% ORBIMED ADVISORS LLC 3Y 7Y 0.33% Nantahala Capital Management, LLC 3Y 7Y 0.24% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.21% Quantedge Capital Pte Ltd 3Y 0.19% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.18% EJF Capital LP 3Y 7Y 0.17% Nantahala Capital Management, LLC 3Y 7Y 0.17% PDT Partners, LLC 3Y 7Y 0.15%
← Back to Squarepoint Ops LLC Holdings